# NOVOsyn® for Trocar Incision After Laparoscopic Appendectomy and Cholecystectomy

> **NCT04033211** · — · COMPLETED · sponsor: **Aesculap AG** · enrollment: 316 (actual)

## Conditions studied

- Appendicitis
- Cholecystitis

## Interventions

- **DEVICE:** Novosyn® CHD for fascia and skin closure
- **DEVICE:** Novosyn® for fascia and skin closure

## Key facts

- **NCT ID:** NCT04033211
- **Lead sponsor:** Aesculap AG
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2020-02-13
- **Primary completion:** 2022-08-24
- **Final completion:** 2023-09-11
- **Target enrollment:** 316 (ACTUAL)
- **Last updated:** 2025-06-18

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04033211

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04033211, "NOVOsyn® for Trocar Incision After Laparoscopic Appendectomy and Cholecystectomy". Retrieved via AI Analytics 2026-05-23 from https://api.ai-analytics.org/clinical/NCT04033211. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*